M86835 M8 Ruling Active

The tariff classification of Play™ Longer from India

Issued October 11, 2006 by U.S. Customs and Border Protection.

Tariff classification

HTS codes: 3004.90.9145

Headings: 3004

Product description

The subject product, Play™ Longer, is a desensitizing lubricant for men containing benzocaine (a topical anesthetic) as the active ingredient. The product is intended for the prevention of premature ejaculation and climax control. It is supplied for retail sale in plastic tubes, each of which contains 1 oz. (28.4g) of lubricant.

CBP rationale

The applicable subheading for the subject product will be 3004.90.9145, Harmonized Tariff Schedule of the United States (HTSUS), which provides for Medicaments…consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other: Other: Dermatological agents and local anesthetics.

Full text

NY M86835 October 11, 2006 CLA-2-30:RR:NC:2:238 M86835 CATEGORY: Classification TARIFF NO.: 3004.90.9145 Mr. Floyd Sirico Rogers & Brown Custom Brokers, Inc. 2 Cumberland Street (29401) P.O. Box 20160 Charleston, SC 29413-0160 RE: The tariff classification of Play™ Longer from India Dear Mr. Sirico: In your letter dated September 18, 2006, on behalf of your client, SSL Americas, Inc., you requested a tariff classification ruling. A sample was submitted with your request. The subject product, Play™ Longer, is a desensitizing lubricant for men containing benzocaine (a topical anesthetic) as the active ingredient. The product is intended for the prevention of premature ejaculation and climax control. It is supplied for retail sale in plastic tubes, each of which contains 1 oz. (28.4g) of lubricant. The applicable subheading for the subject product will be 3004.90.9145, Harmonized Tariff Schedule of the United States (HTSUS), which provides for Medicaments…consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other: Other: Dermatological agents and local anesthetics.” The rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at http://www.usitc.gov/tata/hts/. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Harvey Kuperstein at 646-733-3033. Sincerely, Robert B. Swierupski Director, National Commodity Specialist Division

View original on CBP CROSS →

More rulings on the same tariff codes

Searching CBP rulings the smart way

TariffLens semantically searches all 200,000+ CBP rulings, surfaces the ones that actually match your product, and builds defensible classifications backed by ruling citations.

Book a demo →